Globus Medical, Inc., incorporated on March 3, 2003, is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. The Company's products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative Fusion category products include fusion products to treat spinal disorders for the entire spine, and they can be used in various surgical approaches. The Disruptive Technologies category represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders.
Innovative Fusion
The Company's Innovative Fusion portfolio comprises treatment modalities from the occiput to the sacrum. Its products address the spine to treat degenerative, deformity, tumor and trauma conditions. The Company's pedicle screw platform, CREO, includes a non-threaded locking cap design that eases building of thoracolumbar fixation constructs to adapt to the patient's anatomy and condition, for a range of clinical applications. It also provides streamlined instruments in its CREO platform that offer surgeons options for any situation or preference. Innovative Fusion products are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures. QUARTEX is its Occipito-Cervico-Thoracic (OCT) stabilization system. QUARTEX features a threading locking cap to enable low-torque single step locking and high angle screw heads that accommodate rods of different diameters. The QUARTEX system also includes a range of instruments, including threaded drivers and streamlined reduction tools. The Company's Innovative Fusion products also include the Alphatec products.
Disruptive Technologies
The Company's portfolio of approved and pipeline Disruptive Technology products includes products that allow for minimally invasive surgical (MIS) techniques, as well as treatment alternatives, including motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and biomaterials technologies, as well as interventional pain management solutions, including treatments for vertebral compression fractures. Its MIS products enable a surgeon to perform a procedure less invasively to minimize tissue disruption and maximize native anatomy. It offers various fixation options, including plates and pedicle screw systems designed for minimally invasive insertion.
The Company's other Disruptive Technology products include its motion preservation offerings, such as SECURE-C and SECURE-CR, which are cervical arthroplasty devices that allow segmental motion, are semi-constrained, and provide alternatives to fusion in the treatment of degenerative conditions. Its product, MONUMENT, is an interbody implant for the reduction of a grade 1 spondylolisthesis using its built-in, self-locking mechanical reduction feature. The Company's biomaterials products include bioactive glass-based KINEX and SIGNIFY bone void fillers, and CONDUCT ceramic-collagen, which are suitable for pelvic/extremity and posterolateral spinal fusion procedures. COALITION MIS is an integrated plate-spacer designed to deliver fixation in fewer procedural steps through a less invasive surgical corridor.
The Company competes with Medtronic, Johnson & Johnson, Stryker, NuVasive, Alphatec Spine, Orthofix International, Zimmer, Biomet and K2M.
2560 General Armistead Ave
The company trades on NYSE exchange. The company headquarter is located in Pennsylvania, PA. The company was established in the 2003.| Ticker | GMED |
| Long Name | Globus Medical, Inc. |
| Short Name | Globus Medical |